I generally agree with you, but I would not hold the CEO in such high regards. He made many mistakes which has hurt the shareholders.
1) tMeds were a horrible form of financing.
2) Endako commissioning was horrible. Many mistakes were made.
3) Revolving line of credit was poorly structured, and they were too slow to correct it.